Search Results 11-20 of 3250 for Solid

  1. PTT-936, an Alpha Kinase 1 (ALPK1) Activator, Alone or in Combination with Anti-PD-1/L1 in Patients with Locally Advanced or Metastatic Solid Tumors - Mayo Clinic

    PTT-936, an Alpha Kinase 1 (ALPK1) Activator, Alone or in Combination with Anti-PD-1/L1 in Patients with Locally Advanced or Metastatic Solid Tumors. Print ...

  2. Vilastobart (XTX101) Monotherapy and Vilastobart and Atezolizumab Combination Therapy in Advanced Solid Tumors - Mayo Clinic

    ... solid tumors. Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns ...

  3. Safety and Preliminary Efficacy of OBT076 in Recurrent/​Metastatic CD205+ Solid Tumors - Mayo Clinic

    ... solid tumors for which a standard therapy is not available or is no longer effective. 2. Subject has histologically and/or cytologically confirmed solid tumors.

  4. A Study to Investigate LYL797 in Adults With Solid Tumors - Mayo Clinic

    The purpose of this study is to evaluate the safety and tolerability of LYL797, a ROR1-targeted CAR T-cell therapy, in patients with ROR1+ relapsed or ...

  5. A Study to Evaluate ELU001 in Patients With Solid Tumors That Overexpress Folate Receptor Alpha (FRα) - Mayo Clinic

    A Study to Evaluate ELU001 in Patients With Solid Tumors That Overexpress Folate Receptor Alpha (FRα) · Share · Facebook · Twitter.

  6. Nurse Practitioner or Physician Assistant Solid Organ Transplant Fellowship (Florida) - Health Sciences Education

    Upon graduation, fellows receive a Mayo Clinic School of Health Sciences certificate documenting completion of a 12-month postgraduate fellowship in solid organ ...

  7. Study of rSIFN-co for Patients with Advanced Solid Tumors - Mayo Clinic

    ... solid tumors. Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns ...

  8. A2B101-101: Obtaining Solid Tumor Tissue from Subjects Having Surgical Resection for Certain Tumor Types and Leukapheresis for CAR T-cell Therapy Manufacturing - Mayo Clinic

    A2B101-101: Obtaining Solid Tumor Tissue from Subjects Having Surgical Resection for Certain Tumor Types and Leukapheresis for CAR T-cell Therapy Manufacturing.

  9. A Study of CDX-1127 (Varlilumab) in Patients with Select Solid Tumor Types or Hematologic Cancers - Mayo Clinic

    The study enrolls patients with hematologic cancers (certain leukemias and lymphomas), as well as patients with select types of solid tumors. Participation ...

  10. Cixutumumab in Treating Patients With Relapsed or Refractory Solid Tumors - Mayo Clinic

    This phase II trial is studying the side effects and how well cixutumumab works in treating patients with relapsed or refractory solid tumors. Monoclonal ...